

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of viral latency (GO:0019043) | 4.12345570 |
| 2 | sequestering of actin monomers (GO:0042989) | 4.09485277 |
| 3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.05696714 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 4.02435317 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97505276 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91929651 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91929651 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 3.91929651 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91929651 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.91929651 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91929651 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.85478082 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85478082 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.84904173 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 3.72271851 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51589845 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.26199558 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.22470448 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22470448 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.18361036 |
| 21 | response to interferon-beta (GO:0035456) | 3.16500515 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16383293 |
| 23 | cellular response to interferon-beta (GO:0035458) | 3.13821424 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.12514374 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.12514374 |
| 26 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.10967423 |
| 27 | detection of bacterium (GO:0016045) | 3.10243605 |
| 28 | regulation of defense response to virus by virus (GO:0050690) | 3.08659898 |
| 29 | pentose-phosphate shunt (GO:0006098) | 3.07526110 |
| 30 | protein maturation by protein folding (GO:0022417) | 3.07250721 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.06833219 |
| 32 | B cell mediated immunity (GO:0019724) | 3.06514433 |
| 33 | myeloid dendritic cell activation (GO:0001773) | 3.03819716 |
| 34 | detection of other organism (GO:0098543) | 3.02977019 |
| 35 | NADPH regeneration (GO:0006740) | 3.01581891 |
| 36 | negative regulation of phagocytosis (GO:0050765) | 3.01467669 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01100262 |
| 38 | actin nucleation (GO:0045010) | 3.00420691 |
| 39 | neutrophil activation (GO:0042119) | 2.99264227 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95397067 |
| 41 | cellular response to type I interferon (GO:0071357) | 2.95066480 |
| 42 | type I interferon signaling pathway (GO:0060337) | 2.95066480 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91715895 |
| 44 | response to type I interferon (GO:0034340) | 2.90935971 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89755811 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 2.88694014 |
| 47 | cellular response to zinc ion (GO:0071294) | 2.87519889 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.85044255 |
| 49 | negative thymic T cell selection (GO:0045060) | 2.84737287 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 2.82586842 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82586842 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81279825 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80810279 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 2.80586098 |
| 55 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80130680 |
| 56 | response to peptidoglycan (GO:0032494) | 2.79556809 |
| 57 | dendritic cell chemotaxis (GO:0002407) | 2.79077815 |
| 58 | negative T cell selection (GO:0043383) | 2.78564742 |
| 59 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.76000654 |
| 60 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74624751 |
| 61 | nuclear envelope reassembly (GO:0031468) | 2.74624751 |
| 62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74514529 |
| 63 | granulocyte activation (GO:0036230) | 2.73485392 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 2.71015112 |
| 65 | negative regulation of B cell apoptotic process (GO:0002903) | 2.70636803 |
| 66 | telomere maintenance via recombination (GO:0000722) | 2.70482569 |
| 67 | regulation of RIG-I signaling pathway (GO:0039535) | 2.69915766 |
| 68 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.69794515 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.68708851 |
| 70 | defense response to protozoan (GO:0042832) | 2.67510893 |
| 71 | myeloid dendritic cell differentiation (GO:0043011) | 2.65975620 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65716107 |
| 73 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.65715387 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65149188 |
| 75 | response to host immune response (GO:0052572) | 2.65149188 |
| 76 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.62121160 |
| 77 | negative regulation of ligase activity (GO:0051352) | 2.61457813 |
| 78 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.61457813 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.60756543 |
| 80 | cellular response to interleukin-4 (GO:0071353) | 2.60145900 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59850742 |
| 82 | response to interleukin-15 (GO:0070672) | 2.59517317 |
| 83 | response to muramyl dipeptide (GO:0032495) | 2.59371526 |
| 84 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.58745051 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 2.57812620 |
| 86 | interferon-gamma production (GO:0032609) | 2.57725084 |
| 87 | positive thymic T cell selection (GO:0045059) | 2.57218884 |
| 88 | leukocyte aggregation (GO:0070486) | 2.57063976 |
| 89 | cellular response to interleukin-15 (GO:0071350) | 2.56273830 |
| 90 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.55812774 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 2.55205475 |
| 92 | respiratory burst (GO:0045730) | 2.55103063 |
| 93 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.54250145 |
| 94 | response to interferon-alpha (GO:0035455) | 2.54143876 |
| 95 | response to protozoan (GO:0001562) | 2.53669061 |
| 96 | positive regulation of lamellipodium assembly (GO:0010592) | 2.53458732 |
| 97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.53171991 |
| 98 | dendritic cell migration (GO:0036336) | 2.53102635 |
| 99 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52962869 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.52510281 |
| 101 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.52436611 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51904557 |
| 103 | thymic T cell selection (GO:0045061) | 2.51730731 |
| 104 | DNA strand elongation (GO:0022616) | 2.50224304 |
| 105 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.50062165 |
| 106 | T cell migration (GO:0072678) | 2.49926226 |
| 107 | regulation of B cell differentiation (GO:0045577) | 2.49334677 |
| 108 | response to host (GO:0075136) | 2.49328517 |
| 109 | response to host defenses (GO:0052200) | 2.49328517 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49328517 |
| 111 | positive regulation of macrophage differentiation (GO:0045651) | 2.49213730 |
| 112 | mitotic recombination (GO:0006312) | 2.44987410 |
| 113 | positive regulation of interleukin-12 production (GO:0032735) | 2.43393127 |
| 114 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.42386149 |
| 115 | membrane raft organization (GO:0031579) | 2.41343158 |
| 116 | positive regulation of T cell chemotaxis (GO:0010820) | 2.41127177 |
| 117 | regulation of T cell chemotaxis (GO:0010819) | 2.41127177 |
| 118 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.40978584 |
| 119 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.40749090 |
| 120 | positive regulation of isotype switching (GO:0045830) | 2.40532884 |
| 121 | mast cell activation (GO:0045576) | 2.39796356 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 2.39690797 |
| 123 | proteasome assembly (GO:0043248) | 2.38943265 |
| 124 | dendritic cell differentiation (GO:0097028) | 2.37657182 |
| 125 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.37525236 |
| 126 | DNA deamination (GO:0045006) | 2.37369535 |
| 127 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.37224926 |
| 128 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.37224926 |
| 129 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.37224926 |
| 130 | hepatocyte apoptotic process (GO:0097284) | 2.36993620 |
| 131 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.36820645 |
| 132 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.36820645 |
| 133 | natural killer cell activation (GO:0030101) | 2.36713616 |
| 134 | lymphocyte mediated immunity (GO:0002449) | 2.34750435 |
| 135 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.34190396 |
| 136 | barbed-end actin filament capping (GO:0051016) | 2.33920913 |
| 137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.33496083 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.33321934 |
| 139 | regulation of protein heterodimerization activity (GO:0043497) | 2.33270831 |
| 140 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.33037846 |
| 141 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33020427 |
| 142 | positive regulation of T cell migration (GO:2000406) | 2.29916236 |
| 143 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29545560 |
| 144 | leukocyte mediated cytotoxicity (GO:0001909) | 2.29389009 |
| 145 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.29310148 |
| 146 | positive regulation of interferon-beta production (GO:0032728) | 2.28789425 |
| 147 | regulation of T cell migration (GO:2000404) | 2.27414313 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.25767735 |
| 149 | positive regulation of interleukin-2 production (GO:0032743) | 2.25239195 |
| 150 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.24572393 |
| 151 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.24572393 |
| 152 | regulation of response to interferon-gamma (GO:0060330) | 2.24124552 |
| 153 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.23759505 |
| 154 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.23619591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.76808303 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.57069950 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21675045 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.75215280 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58858642 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15416808 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92373772 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88668146 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62066176 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56232671 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55697312 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55449738 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54582591 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.48741092 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48555883 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42613743 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.32940710 |
| 18 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.30065372 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23173154 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20924269 |
| 21 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15264395 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15215117 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09646868 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.09507765 |
| 25 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08369448 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.08070919 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.06999610 |
| 28 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.04353561 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02064173 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01879392 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97696896 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94920656 |
| 33 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.90179429 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87032104 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85742951 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.82999918 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82473131 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.81451119 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77860675 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.72706359 |
| 41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.65279988 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62807157 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62611846 |
| 44 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.62398634 |
| 45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62280540 |
| 46 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62076642 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59820074 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59683275 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.59624357 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59162033 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56909549 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.56428970 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54204650 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48909906 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47453697 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.45761848 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44364833 |
| 58 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42309597 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42032150 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41902758 |
| 61 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.41629856 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41463189 |
| 63 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41335286 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37621148 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37516855 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33320775 |
| 67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.33224518 |
| 68 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.32839704 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30207434 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30138166 |
| 71 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.30078426 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29812929 |
| 73 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29608415 |
| 74 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27448760 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25472523 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25161159 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24176271 |
| 78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23941180 |
| 79 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.23743744 |
| 80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22509276 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22363087 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22186989 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21867364 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21494789 |
| 85 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20185964 |
| 86 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19774868 |
| 87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19084257 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17093244 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16659283 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16447897 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15745960 |
| 92 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14590263 |
| 93 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14333858 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12723888 |
| 95 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.12682095 |
| 96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12275317 |
| 97 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10882255 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10078124 |
| 99 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08734006 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08454265 |
| 101 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.08402743 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07492035 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06699096 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05848006 |
| 105 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05614399 |
| 106 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04811279 |
| 107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04350140 |
| 108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04335570 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03613704 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03456697 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02717608 |
| 112 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02571897 |
| 113 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02024754 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01254276 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00511691 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00196060 |
| 117 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.99666876 |
| 118 | * MAF_26560356_Chip-Seq_TH2_Human | 0.97738242 |
| 119 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96985758 |
| 120 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96417523 |
| 121 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96191006 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90655282 |
| 123 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90270737 |
| 124 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89580210 |
| 125 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.89227251 |
| 126 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89091381 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88859307 |
| 128 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88313992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.45219663 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.23439847 |
| 3 | MP0005671_abnormal_response_to | 3.18460018 |
| 4 | MP0009785_altered_susceptibility_to | 3.08349922 |
| 5 | MP0000685_abnormal_immune_system | 2.93771663 |
| 6 | MP0008260_abnormal_autophagy | 2.84719560 |
| 7 | MP0003436_decreased_susceptibility_to | 2.77445952 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.65237838 |
| 9 | MP0001790_abnormal_immune_system | 2.50202013 |
| 10 | MP0005387_immune_system_phenotype | 2.50202013 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.49313486 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.47222532 |
| 13 | MP0001800_abnormal_humoral_immune | 2.43919660 |
| 14 | MP0005025_abnormal_response_to | 2.39828142 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.30108037 |
| 16 | MP0001819_abnormal_immune_cell | 2.29192268 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.28710114 |
| 18 | MP0002419_abnormal_innate_immunity | 2.28374306 |
| 19 | MP0002723_abnormal_immune_serum | 2.27508424 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.21025262 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.11665956 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.09817603 |
| 23 | MP0002398_abnormal_bone_marrow | 2.03896696 |
| 24 | MP0002405_respiratory_system_inflammati | 2.01871138 |
| 25 | MP0002006_tumorigenesis | 2.01851906 |
| 26 | MP0003724_increased_susceptibility_to | 1.97677385 |
| 27 | MP0001853_heart_inflammation | 1.95658488 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.91366922 |
| 29 | MP0000716_abnormal_immune_system | 1.84462439 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.81070075 |
| 31 | MP0006082_CNS_inflammation | 1.77299760 |
| 32 | MP0000858_altered_metastatic_potential | 1.75551517 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.73728686 |
| 34 | MP0008057_abnormal_DNA_replication | 1.69914862 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.68019571 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.66315335 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.65171803 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.64431879 |
| 39 | MP0003077_abnormal_cell_cycle | 1.63039466 |
| 40 | MP0002722_abnormal_immune_system | 1.62810405 |
| 41 | MP0002429_abnormal_blood_cell | 1.59339624 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.53830643 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.53830643 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.50199609 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.50037772 |
| 46 | MP0000490_abnormal_crypts_of | 1.49545933 |
| 47 | MP0003448_altered_tumor_morphology | 1.48827400 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.44162960 |
| 49 | MP0004510_myositis | 1.39966223 |
| 50 | MP0005451_abnormal_body_composition | 1.39752713 |
| 51 | MP0008058_abnormal_DNA_repair | 1.38981316 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.38474332 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.37056144 |
| 54 | MP0006054_spinal_hemorrhage | 1.34593442 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.33543750 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.31181239 |
| 57 | MP0003303_peritoneal_inflammation | 1.30818002 |
| 58 | MP0002163_abnormal_gland_morphology | 1.26742656 |
| 59 | MP0001849_ear_inflammation | 1.24631656 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.23886167 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.21542181 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21066239 |
| 63 | MP0004947_skin_inflammation | 1.16818528 |
| 64 | MP0003279_aneurysm | 1.14813026 |
| 65 | MP0010307_abnormal_tumor_latency | 1.13489394 |
| 66 | MP0002009_preneoplasia | 1.13312579 |
| 67 | MP0000343_altered_response_to | 1.13078493 |
| 68 | MP0003186_abnormal_redox_activity | 1.10973157 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.07963685 |
| 70 | MP0001873_stomach_inflammation | 1.06880626 |
| 71 | MP0000358_abnormal_cell_content/ | 1.05926161 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 1.05763041 |
| 73 | MP0008469_abnormal_protein_level | 1.03526175 |
| 74 | * MP0002019_abnormal_tumor_incidence | 1.03166380 |
| 75 | MP0001730_embryonic_growth_arrest | 1.03015172 |
| 76 | MP0005621_abnormal_cell_physiology | 1.02890540 |
| 77 | MP0005310_abnormal_salivary_gland | 1.01361266 |
| 78 | MP0003075_altered_response_to | 1.01194083 |
| 79 | MP0002933_joint_inflammation | 1.00812742 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.98664599 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.97375180 |
| 82 | MP0003786_premature_aging | 0.97296194 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.95262689 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.93946965 |
| 85 | MP0002132_abnormal_respiratory_system | 0.93236352 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.92895220 |
| 87 | MP0009764_decreased_sensitivity_to | 0.92572333 |
| 88 | MP0005384_cellular_phenotype | 0.91796963 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.91386248 |
| 90 | MP0003866_abnormal_defecation | 0.91311518 |
| 91 | MP0009763_increased_sensitivity_to | 0.90272215 |
| 92 | MP0008932_abnormal_embryonic_tissue | 0.88954386 |
| 93 | MP0005023_abnormal_wound_healing | 0.88713565 |
| 94 | MP0005390_skeleton_phenotype | 0.87095377 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.87035088 |
| 96 | MP0003943_abnormal_hepatobiliary_system | 0.87007068 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.86459915 |
| 98 | MP0001542_abnormal_bone_strength | 0.86194437 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.85249153 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.85036764 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.84334493 |
| 102 | MP0004883_abnormal_blood_vessel | 0.81593116 |
| 103 | MP0000313_abnormal_cell_death | 0.81361767 |
| 104 | MP0000350_abnormal_cell_proliferation | 0.81058277 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.80153869 |
| 106 | MP0001915_intracranial_hemorrhage | 0.79510759 |
| 107 | MP0005501_abnormal_skin_physiology | 0.79200957 |
| 108 | MP0003941_abnormal_skin_development | 0.78570129 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.78050325 |
| 110 | MP0003828_pulmonary_edema | 0.77864912 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.77604766 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.77550643 |
| 113 | * MP0002080_prenatal_lethality | 0.76454441 |
| 114 | MP0003091_abnormal_cell_migration | 0.75718853 |
| 115 | MP0003705_abnormal_hypodermis_morpholog | 0.75536932 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.73964607 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.73083142 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.71901726 |
| 119 | MP0002254_reproductive_system_inflammat | 0.71369645 |
| 120 | MP0009278_abnormal_bone_marrow | 0.71319894 |
| 121 | MP0001851_eye_inflammation | 0.70723521 |
| 122 | MP0001529_abnormal_vocalization | 0.70594587 |
| 123 | MP0005165_increased_susceptibility_to | 0.69806332 |
| 124 | MP0001243_abnormal_dermal_layer | 0.69750394 |
| 125 | MP0001958_emphysema | 0.68096988 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.66661483 |
| 127 | MP0000371_diluted_coat_color | 0.58254589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.93048298 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59032970 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.49577883 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.30044971 |
| 5 | Myositis (HP:0100614) | 4.11576975 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 3.51980896 |
| 7 | Thrombocytosis (HP:0001894) | 3.40070382 |
| 8 | Increased IgM level (HP:0003496) | 3.37992756 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.19807823 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.18941091 |
| 11 | Optic neuritis (HP:0100653) | 3.18941091 |
| 12 | Cholecystitis (HP:0001082) | 3.18903585 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.18903585 |
| 14 | Orchitis (HP:0100796) | 3.18272963 |
| 15 | Recurrent viral infections (HP:0004429) | 3.07106515 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.03957407 |
| 17 | Petechiae (HP:0000967) | 2.99560672 |
| 18 | Abnormality of macrophages (HP:0004311) | 2.98114339 |
| 19 | IgM deficiency (HP:0002850) | 2.95481854 |
| 20 | Hepatosplenomegaly (HP:0001433) | 2.94940140 |
| 21 | Urticaria (HP:0001025) | 2.91658191 |
| 22 | Obstructive lung disease (HP:0006536) | 2.89707070 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89707070 |
| 24 | Spinal cord lesions (HP:0100561) | 2.85859344 |
| 25 | Syringomyelia (HP:0003396) | 2.85859344 |
| 26 | Chronic otitis media (HP:0000389) | 2.81490093 |
| 27 | Recurrent skin infections (HP:0001581) | 2.77851019 |
| 28 | Abnormality of T cell number (HP:0011839) | 2.77306694 |
| 29 | Vasculitis (HP:0002633) | 2.76272052 |
| 30 | Eosinophilia (HP:0001880) | 2.73437292 |
| 31 | Granulocytopenia (HP:0001913) | 2.70072619 |
| 32 | Poor head control (HP:0002421) | 2.69270207 |
| 33 | Cellulitis (HP:0100658) | 2.68562188 |
| 34 | Chest pain (HP:0100749) | 2.65026945 |
| 35 | Meningitis (HP:0001287) | 2.64955886 |
| 36 | Abnormality of T cells (HP:0002843) | 2.61258994 |
| 37 | IgG deficiency (HP:0004315) | 2.60940890 |
| 38 | Abnormality of the anterior horn cell (HP:0006802) | 2.60771929 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.60771929 |
| 40 | Cortical dysplasia (HP:0002539) | 2.60217586 |
| 41 | Hypertensive crisis (HP:0100735) | 2.59599886 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59429489 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.57103661 |
| 44 | Leukocytosis (HP:0001974) | 2.55748442 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.52577423 |
| 46 | Increased mean platelet volume (HP:0011877) | 2.50074188 |
| 47 | Basal ganglia calcification (HP:0002135) | 2.49427046 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 2.47587423 |
| 49 | Rough bone trabeculation (HP:0100670) | 2.47312527 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.47163407 |
| 51 | T lymphocytopenia (HP:0005403) | 2.46734483 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.45470712 |
| 53 | Recurrent pneumonia (HP:0006532) | 2.45256824 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43988129 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43988129 |
| 56 | Reticulocytopenia (HP:0001896) | 2.42535004 |
| 57 | 11 pairs of ribs (HP:0000878) | 2.42356805 |
| 58 | Spastic diplegia (HP:0001264) | 2.40816918 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38218671 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.37942795 |
| 61 | Sepsis (HP:0100806) | 2.36534089 |
| 62 | Aplastic anemia (HP:0001915) | 2.34752649 |
| 63 | Pustule (HP:0200039) | 2.34032584 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.33344453 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31959399 |
| 66 | Prostate neoplasm (HP:0100787) | 2.30719298 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.30316652 |
| 68 | Increased IgE level (HP:0003212) | 2.30165400 |
| 69 | IgA deficiency (HP:0002720) | 2.30012849 |
| 70 | Lymphopenia (HP:0001888) | 2.27940658 |
| 71 | Lymphoma (HP:0002665) | 2.27675929 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.26795749 |
| 73 | Upper limb muscle weakness (HP:0003484) | 2.26729793 |
| 74 | Severe combined immunodeficiency (HP:0004430) | 2.25367176 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.25128811 |
| 76 | Entropion (HP:0000621) | 2.24420392 |
| 77 | Verrucae (HP:0200043) | 2.23254517 |
| 78 | Papilloma (HP:0012740) | 2.23254517 |
| 79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21024365 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20551409 |
| 81 | Periodontitis (HP:0000704) | 2.17919647 |
| 82 | Pelvic girdle muscle weakness (HP:0003749) | 2.16108380 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.16085184 |
| 84 | Chromsome breakage (HP:0040012) | 2.15263857 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.14789412 |
| 86 | Gingivitis (HP:0000230) | 2.14515275 |
| 87 | Agnosia (HP:0010524) | 2.13090461 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 2.12140902 |
| 89 | Microvesicular hepatic steatosis (HP:0001414) | 2.10967501 |
| 90 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10663639 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.10663639 |
| 92 | Encephalitis (HP:0002383) | 2.10145758 |
| 93 | Epistaxis (HP:0000421) | 2.09141817 |
| 94 | Combined immunodeficiency (HP:0005387) | 2.08989390 |
| 95 | Osteomyelitis (HP:0002754) | 2.08100046 |
| 96 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.07034775 |
| 97 | Panhypogammaglobulinemia (HP:0003139) | 2.05216821 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.04522964 |
| 99 | Prolonged bleeding time (HP:0003010) | 2.02621241 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 2.01846106 |
| 101 | Shoulder girdle muscle weakness (HP:0003547) | 2.01775052 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 2.01697791 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 1.99719772 |
| 104 | Hemoptysis (HP:0002105) | 1.99305817 |
| 105 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.97108266 |
| 106 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.97108266 |
| 107 | Amaurosis fugax (HP:0100576) | 1.96485032 |
| 108 | Skin ulcer (HP:0200042) | 1.95891004 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 1.95386978 |
| 110 | Type I transferrin isoform profile (HP:0003642) | 1.94547040 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.94469321 |
| 112 | Thyroiditis (HP:0100646) | 1.94425662 |
| 113 | Chronic diarrhea (HP:0002028) | 1.93883306 |
| 114 | Arterial thrombosis (HP:0004420) | 1.93013290 |
| 115 | Increased density of long bones (HP:0006392) | 1.92239834 |
| 116 | Skin rash (HP:0000988) | 1.92063840 |
| 117 | Glomerulopathy (HP:0100820) | 1.91510916 |
| 118 | Pulmonary fibrosis (HP:0002206) | 1.90638406 |
| 119 | Premature rupture of membranes (HP:0001788) | 1.89852467 |
| 120 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89507580 |
| 121 | Selective tooth agenesis (HP:0001592) | 1.89452305 |
| 122 | Inflammation of the large intestine (HP:0002037) | 1.87163125 |
| 123 | Micronodular cirrhosis (HP:0001413) | 1.87017379 |
| 124 | Stomatitis (HP:0010280) | 1.86998305 |
| 125 | Birth length less than 3rd percentile (HP:0003561) | 1.86772886 |
| 126 | Viral hepatitis (HP:0006562) | 1.85431499 |
| 127 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84988319 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 1.83837854 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83476165 |
| 130 | Abnormal neuron morphology (HP:0012757) | 1.80774519 |
| 131 | Abnormality of the motor neurons (HP:0002450) | 1.80774519 |
| 132 | Reduced antithrombin III activity (HP:0001976) | 1.80769590 |
| 133 | Acute hepatic failure (HP:0006554) | 1.80492817 |
| 134 | Recurrent sinusitis (HP:0011108) | 1.79499201 |
| 135 | Abnormal number of erythroid precursors (HP:0012131) | 1.79381805 |
| 136 | Impaired platelet aggregation (HP:0003540) | 1.79376494 |
| 137 | Abnormal platelet function (HP:0011869) | 1.79376494 |
| 138 | Abnormal platelet volume (HP:0011876) | 1.79310407 |
| 139 | Cleft eyelid (HP:0000625) | 1.79089695 |
| 140 | Abnormality of the pleura (HP:0002103) | 1.78697949 |
| 141 | Clubbing of toes (HP:0100760) | 1.77244223 |
| 142 | Acute myeloid leukemia (HP:0004808) | 1.75731762 |
| 143 | B lymphocytopenia (HP:0010976) | 1.75713085 |
| 144 | Abnormality of B cell number (HP:0010975) | 1.75713085 |
| 145 | Exertional dyspnea (HP:0002875) | 1.75655364 |
| 146 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.73415526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.78311268 |
| 2 | MAP3K14 | 3.73431694 |
| 3 | SMG1 | 2.87967128 |
| 4 | PIM2 | 2.80802872 |
| 5 | IRAK4 | 2.73352840 |
| 6 | MAP4K1 | 2.68357542 |
| 7 | TXK | 2.58584842 |
| 8 | JAK3 | 2.34725069 |
| 9 | TESK1 | 2.30491104 |
| 10 | TESK2 | 2.29162829 |
| 11 | BLK | 2.28591651 |
| 12 | NME2 | 2.25105712 |
| 13 | EIF2AK1 | 2.15945955 |
| 14 | TBK1 | 2.07695729 |
| 15 | TYK2 | 2.04913556 |
| 16 | BUB1 | 2.04177289 |
| 17 | IKBKE | 1.98974698 |
| 18 | IKBKB | 1.93960860 |
| 19 | KIT | 1.87984476 |
| 20 | PRPF4B | 1.75611782 |
| 21 | ERBB3 | 1.72369029 |
| 22 | IRAK3 | 1.72054555 |
| 23 | ERN1 | 1.70023298 |
| 24 | EPHB1 | 1.64825376 |
| 25 | SIK3 | 1.64750212 |
| 26 | RPS6KA4 | 1.63739074 |
| 27 | ZAK | 1.63273275 |
| 28 | KDR | 1.55996829 |
| 29 | TRIM28 | 1.53172977 |
| 30 | BCKDK | 1.51984570 |
| 31 | PIM1 | 1.47732990 |
| 32 | ZAP70 | 1.46118292 |
| 33 | NEK9 | 1.45426311 |
| 34 | TEC | 1.44131101 |
| 35 | CHUK | 1.42774312 |
| 36 | BTK | 1.36943764 |
| 37 | MST4 | 1.36090444 |
| 38 | TGFBR1 | 1.34322439 |
| 39 | VRK1 | 1.33641236 |
| 40 | MKNK1 | 1.32681187 |
| 41 | DAPK1 | 1.32639904 |
| 42 | PBK | 1.31822414 |
| 43 | WEE1 | 1.28123643 |
| 44 | STK10 | 1.26813712 |
| 45 | LIMK1 | 1.25299630 |
| 46 | CLK1 | 1.24273627 |
| 47 | EIF2AK3 | 1.22755834 |
| 48 | EIF2AK2 | 1.22516036 |
| 49 | PLK4 | 1.21583365 |
| 50 | SYK | 1.21447647 |
| 51 | NEK1 | 1.16543159 |
| 52 | BMPR2 | 1.16231368 |
| 53 | CSF1R | 1.15876310 |
| 54 | CDK19 | 1.15029890 |
| 55 | TLK1 | 1.14998035 |
| 56 | SRPK1 | 1.13576145 |
| 57 | ACVR1B | 1.12152854 |
| 58 | ARAF | 1.11277253 |
| 59 | TAF1 | 1.09702792 |
| 60 | TRPM7 | 1.08301863 |
| 61 | STK16 | 1.07389148 |
| 62 | STK4 | 1.05944246 |
| 63 | FES | 1.01013815 |
| 64 | NLK | 1.00719552 |
| 65 | FGR | 0.98735009 |
| 66 | CDC7 | 0.95855899 |
| 67 | LCK | 0.94510585 |
| 68 | LYN | 0.90935973 |
| 69 | TTN | 0.88107250 |
| 70 | MAP3K12 | 0.87715203 |
| 71 | TSSK6 | 0.86575625 |
| 72 | NUAK1 | 0.83402551 |
| 73 | LRRK2 | 0.80342943 |
| 74 | JAK1 | 0.80328319 |
| 75 | CSK | 0.79670561 |
| 76 | ITK | 0.79164185 |
| 77 | YES1 | 0.78717709 |
| 78 | BRSK2 | 0.77572128 |
| 79 | ATR | 0.76616540 |
| 80 | AURKA | 0.75884765 |
| 81 | CSNK1G3 | 0.75026705 |
| 82 | GRK6 | 0.74054727 |
| 83 | FLT3 | 0.74043659 |
| 84 | HCK | 0.73219949 |
| 85 | TAOK1 | 0.71577955 |
| 86 | BMPR1B | 0.71134654 |
| 87 | RIPK4 | 0.67620928 |
| 88 | PAK4 | 0.66147700 |
| 89 | MAPKAPK2 | 0.66021612 |
| 90 | ALK | 0.65404842 |
| 91 | RPS6KB2 | 0.64922425 |
| 92 | CDK14 | 0.63289904 |
| 93 | DAPK3 | 0.62610850 |
| 94 | DYRK2 | 0.60950870 |
| 95 | TAOK2 | 0.60538435 |
| 96 | RPS6KA5 | 0.60431131 |
| 97 | CSNK1A1L | 0.58228451 |
| 98 | AURKB | 0.57379712 |
| 99 | RPS6KA6 | 0.56860822 |
| 100 | PLK3 | 0.55728274 |
| 101 | EPHA3 | 0.55466976 |
| 102 | ABL2 | 0.54909602 |
| 103 | MAP2K3 | 0.54092703 |
| 104 | MAP3K8 | 0.52293136 |
| 105 | FGFR3 | 0.52236819 |
| 106 | CDK7 | 0.52056992 |
| 107 | TGFBR2 | 0.51097308 |
| 108 | PRKCD | 0.51016846 |
| 109 | EPHA2 | 0.50796863 |
| 110 | MOS | 0.50062636 |
| 111 | ERBB4 | 0.49982593 |
| 112 | MAP3K5 | 0.47883408 |
| 113 | CDK18 | 0.47800247 |
| 114 | CDK4 | 0.47710217 |
| 115 | MKNK2 | 0.47631314 |
| 116 | MYLK | 0.47618201 |
| 117 | MATK | 0.47428425 |
| 118 | RPS6KL1 | 0.47089094 |
| 119 | RPS6KC1 | 0.47089094 |
| 120 | ROCK2 | 0.46748413 |
| 121 | MAP3K11 | 0.45765453 |
| 122 | PASK | 0.44531465 |
| 123 | ADRBK2 | 0.43789917 |
| 124 | MAP2K7 | 0.43516337 |
| 125 | SCYL2 | 0.43469225 |
| 126 | PLK1 | 0.43067907 |
| 127 | RAF1 | 0.42772021 |
| 128 | MAP3K3 | 0.42618409 |
| 129 | CDK8 | 0.41891304 |
| 130 | CCNB1 | 0.41421032 |
| 131 | CDK15 | 0.40283817 |
| 132 | PTK6 | 0.40266018 |
| 133 | CDK11A | 0.39916009 |
| 134 | BCR | 0.37940214 |
| 135 | CSNK1G2 | 0.35729682 |
| 136 | PAK1 | 0.35537291 |
| 137 | JAK2 | 0.35151454 |
| 138 | PRKD2 | 0.33838898 |
| 139 | FYN | 0.32299372 |
| 140 | CDK9 | 0.32189693 |
| 141 | PRKCQ | 0.30183429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.84278393 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.81775853 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55703278 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.51862670 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40543145 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18720695 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13579318 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.12209435 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.05409295 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02996705 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02284484 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.01597298 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.97629190 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85990010 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79757064 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.75504927 |
| 17 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.69062421 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68103887 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.64796646 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.63192483 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61134048 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60776103 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.55042863 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.54897726 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52362523 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50287293 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49704039 |
| 28 | * Shigellosis_Homo sapiens_hsa05131 | 1.48351149 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43540893 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40548815 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38901877 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.37238671 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36925643 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.35963747 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33583893 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33233588 |
| 37 | * Influenza A_Homo sapiens_hsa05164 | 1.32594372 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30971033 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29066184 |
| 40 | * Apoptosis_Homo sapiens_hsa04210 | 1.27852795 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.24612063 |
| 42 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.24402253 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.23182811 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21717641 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19809964 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19541642 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17186955 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16520031 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16065803 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15233120 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13450726 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.12288771 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11337888 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 1.10341355 |
| 55 | * Salmonella infection_Homo sapiens_hsa05132 | 1.09313652 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06324109 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05357654 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.04924976 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03463668 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03269537 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.01724081 |
| 62 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00839525 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97696067 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92727075 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91575788 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91322776 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90865676 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90078810 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89854752 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.88960478 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88764660 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87883026 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.86106525 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83779519 |
| 75 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81772873 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81214543 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80600990 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79266086 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75111751 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73522022 |
| 81 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71885834 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70417237 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69871854 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69722719 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69358006 |
| 86 | * Phagosome_Homo sapiens_hsa04145 | 0.69098867 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68701668 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67975837 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67845913 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67409531 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61986033 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.61542841 |
| 93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59994102 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58890359 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57648714 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.55201841 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.54442171 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.53653145 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53311085 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53096218 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52546929 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52470889 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51956672 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48016392 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47594884 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45028994 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44880696 |
| 108 | * Platelet activation_Homo sapiens_hsa04611 | 0.44754057 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43478537 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.40730850 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39493123 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37537925 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37269131 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37180670 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36994894 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36873173 |
| 117 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35896014 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35848396 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34299382 |
| 120 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33715057 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32944910 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30722550 |
| 123 | * Adherens junction_Homo sapiens_hsa04520 | 0.30612745 |

